Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways-MedSci.cn

Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways

Yang, WW; Zhu, LWS; Lai, SL; Ding, QC; Xu, TT; Guo, R; Dou, XB; Chai, H; Yu, ZL; Li, ST

Li, ST (通讯作者)，Zhejiang Chinese Med Univ, Sch Publ Hlth, Hangzhou 310053, Peoples R China.;Li, ST (通讯作者)，Zhejiang Chinese Med Univ, Chinese Acad Med Sci, Hangzhou 310053, Zhejiang, Peoples R China.;Li, ST (通讯作者)，Zhejiang Chinese Med Univ, Inst Nutr & Hlth, Hangzhou 310053, Peoples R China.

Abstract

Objective. Hepatic metabolic disorder induced by lipotoxicity plays a detrimental role in metabolic fatty liver disease pathogenesis. Cimifugin (Cim),......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways

科室

工具

服务